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Ehrlichiosis and anaplasmosis are tick-borne diseases caused by obligate 
intracellular bacteria in the genera Ehrlichia and Anaplasma. These organisms are 
widespread in nature; the reservoir hosts include numerous wild animals, as well as 
some domesticated species. For many years, Ehrlichia and Anaplasma species have 
been known to cause illness in pets and livestock. The consequences of exposure vary 
from asymptomatic infections to severe, potentially fatal illness. Some organisms 
have also been recognized as human pathogens since the 1980s and 1990s.  
Etiology 
Ehrlichiosis and anaplasmosis are caused by members of the genera Ehrlichia 
and Anaplasma, respectively. Both genera contain small, pleomorphic, Gram negative, 
obligate intracellular organisms, and belong to the family Anaplasmataceae, order 
Rickettsiales. They are classified as α-proteobacteria. A number of Ehrlichia and 
Anaplasma species affect animals. A limited number of these organisms have also 
been identified in people. 
Recent changes in taxonomy can make the nomenclature of the Anaplasmataceae 
and their diseases somewhat confusing. At one time, ehrlichiosis was a group of 
diseases caused by organisms that mostly replicated in membrane-bound cytoplasmic 
vacuoles of leukocytes, and belonged to the genus Ehrlichia, tribe Ehrlichieae and 
family Rickettsiaceae. The names of the diseases were often based on the host 
species, together with type of leukocyte most often infected. For example, Ehrlichia 
equi mainly infected neutrophils and caused illness in horses; thus, the name of the 
disease was equine granulocytic ehrlichiosis. After 2001, some species of Ehrlichia 
were reclassified into the genera Anaplasma or Neorickettsia, and all three genera 
were placed in the family Anaplasmataceae. In addition, Ehrlichia equi, together with 
E. phagocytophila (which causes disease in ruminants) and “the agent of human 
granulocytic ehrlichiosis” became the single species Anaplasma phagocytophilum. As 
a result, the names of some diseases also changed. For instance, equine granulocytic 
ehrlichiosis eventually became known as equine granulocytic anaplasmosis. 
Additional confusion results from the recognition that more than one pathogenic 
Ehrlichia species may infect granulocytes or monocytes in some hosts. 
Currently, the genus Ehrlichia contains five recognized species: E. canis, E. 
chaffeensis, E. ewingii, E. muris and E. ruminantium. E. canis causes canine 
monocytic ehrlichiosis (CME). This organism has been implicated rarely in human 
illness. E. chaffeensis also infects monocytes, causing illness in both dogs and people. 
In people, this disease is called human monocytic ehrlichiosis (HME). E. ewingii 
infects granulocytes and is zoonotic. The illness is sometimes known as canine 
granulocytic ehrlichiosis in dogs; however, human ewingii ehrlichiosis (HEE) is now 
the preferred name for the disease in people, to avoid confusion with the old name for 
the illness caused by A. phagocytophilum. E. muris, which infects monocytes in 
rodents, might also be zoonotic. E. ruminantium (formerly Cowdria ruminantium) is 
the agent of heartwater in ruminants (see the heartwater factsheet for further 
information). E. ruminantium is not thought to be zoonotic, but a report describing 
several infected people in South Africa suggests that this might need to be reassessed.  
The currently recognized species in the genus Anaplasma are A. 
phagocytophilum, A. platys (formerly E. platys), A. marginale (and A. marginale 
subsp. centrale), A. bovis (formerly E. bovis) and A. ovis. Anaplasma 
phagocytophilum infects humans and many species of animals. The disease is known 
as human granulocytic anaplasmosis (HGA; formerly human granulocytic 
ehrlichiosis) in people, canine granulocytic anaplasmosis (previously canine 
granulocytic ehrlichiosis) in dogs, equine granulocytic anaplasmosis (formerly equine 
granulocytic ehrlichiosis) in horses, and tick-borne fever in ruminants. A. 
phagocytophilum is a very heterogeneous organism, and genetic variants can differ in 
their virulence for host species. In addition, the isolates maintained in some animal 
reservoir hosts might not affect people. The remaining Anaplasma species are not 
thought to be zoonotic. A. platys infects platelets and causes cyclic canine 
thrombocytopenia, while A. marginale, A. bovis and A. ovis infect erythrocytes of  
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domesticated and wild ruminants. A recent study described 
A. ovis nucleic acids in a person with an ehrlichiosis-like 
illness in Cyprus, but a causative role remains to be 
confirmed.  
Potential new members of Ehrlichia and Anaplasma 
continue to be discovered. An organism related to E. 
ruminantium, and known as “the Panola Mountain 
Ehrlichia,” infects deer in North America. Little is known 
about this organism, but it was recently implicated in a case 
of human ehrlichiosis in the U.S. It can also cause signs of 
ehrlichiosis in experimentally infected goats. In 2011, an 
organism closely related to E. muris was identified in 4 
patients with confirmed ehrlichiosis in Minnesota and 
Wisconsin. This organism is currently referred to as 
“ehrlichia species Wisconsin” or the “E. muris-like” 
organism. Detection of a novel Ehrlichia species in North 
American cattle was reported in 2010, and a novel E. canis-
related organism might infect felids in South America. 
Additional Ehrlichia and Anaplasma species, of unknown 
pathogenicity for humans or animals, have been identified in 
ticks worldwide.  
Some former Ehrlichia species have been reclassified 
into other genera among the Anaplasmataceae. 
Neorickettsia risticii (formerly Ehrlichia risticii) causes 
Potomac horse fever, which is also known as equine 
monocytic ehrlichiosis. N. sennetsu (previously E. 
sennetsu) also infects monocytes and is the agent of 
sennetsu fever in humans. N. elokominica causes elokomin 
fluke fever in several species of animals, and N. 
helminthoeca causes salmon poisoning disease in canids. 
The Neorickettsia species, whose life cycles are now known 
to involve trematodes rather than ticks, will not be 
discussed further. 
Geographic Distribution 
E. canis and A. phagocytophilum occur worldwide, 
although their distribution within an area varies with the 
presence and density of their tick vectors. Within the U.S., 
infections caused by A. phagocytophilum are mainly 
reported in the Upper Midwest and northeastern and 
western states.  
E. chaffeensis was originally described from North 
America, but it was recently detected in parts of South 
America, Asia and Africa. It is possible that some of these 
reports involve other closely-related organisms. Within the 
U.S., E. chaffeensis infections occur mainly in the 
southeastern, south-central and mid-Atlantic states, where 
its major tick vector (Amblyomma americanum) is endemic.  
E. ewingii is also transmitted by Am. americanum in 
North America, and it has been found in deer, other animals 
and ticks throughout this tick’s range. Only a few human 
cases have been documented, mainly in Tennessee, 
Missouri and Oklahoma. E. ewingii was recently detected in 
South America and Cameroon, Africa. 
E. muris has been found in I. persulcatus complex ticks 
from Eastern Europe to Japan, and was linked to human 
illness in Russia. A closely related organism was recently 
described in human patients in North America.  
In some cases, disease syndromes are not reported 
from an organism’s entire geographic range. Anaplasma 
phagocytophilum seems to be especially heterogeneous. 
Although this organism affects humans, horses, dogs and 
cats in both Eastern and Western Hemispheres, the 
variants found in the Americas do not seem to cause 
illness in ruminants.  
Transmission 
Ehrlichia and Anaplasma are transmitted by ticks in 
the family Ixodidae. These organisms are usually 
maintained in cycles between ticks and wild or 
domesticated animal reservoir hosts, which can sometimes 
remain infected for long periods.  
Rhipicephalus sanguineus, the brown dog tick, is the 
primary vector for Ehrlichia canis. E. canis can also be 
transmitted experimentally by Dermacentor variabilis, the 
American dog tick. Other secondary vectors, such as 
Amblyomma cajennense, have been suggested. Am. 
americanum (the Lone Star tick) is the most important 
vector for both E. chaffeensis and E. ewingii in North 
America. Secondary vectors such as D. variabilis and R. 
sanguineus might have a minor role in transmission to 
humans and domesticated animals. Outside North America, 
E. chaffeensis has been found in ticks in the genera 
Amblyomma, Haemaphysalis, Dermacentor and Ixodes in 
Asia, in R. sanguineus in Cameroon, and in Am. parvum in 
Argentina. E. muris can be transmitted by Haemaphysalis 
flava and Ixodes persulcatus complex ticks. Anaplasma 
phagocytophilum is transmitted by Ixodes species. The 
major vectors in North America are Ixodes scapularis (the 
black-legged tick) and I. pacificus (the Western black-
legged tick or Pacific tick). I. ricinus transmits A. 
phagocytophilum in Europe, and I. persulcatus is the major 
vector in Asia. This organism can also be found in other 
tick vectors, such as I. trianguliceps in the U.K. or I. 
spinipalpis in the U.S.; however, they do not seem to be 
important in transmitting it to people or domesticated 
animals. Genetic variants of A. phagocytophilum might be 
adapted to different reservoir hosts and/or tick species and 
maintained in distinct cycles. 
Transstadial transmission is thought to be important in 
the life cycles of Ehrlichia and Anaplasma spp. It has been 
experimentally demonstrated for E. canis in R. sanguineus, 
and E. chaffeensis and E. ewingii in Am. americanum. 
Transovarial transmission has never been shown and is not 
thought to occur (although it remains possible that tick eggs 
are infected at a very low frequency).  
Anaplasma and Ehrlichia may occasionally be 
transmitted by other routes, especially in medical 
procedures that transfer blood or bone marrow. There are a 
few reports of human A. phagocytophilum infections 
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acquired in blood transfusions, and E. chaffeensis infections 
were apparently transmitted in solid organ transplants. 
Some Ehrlichia spp. can remain viable for more than a 
week in preserved, refrigerated whole blood. Transmission 
on contaminated needles and mechanical transmission by 
biting insects are also theoretically possible. Three human 
infections with A. phagocytophilum might have acquired 
from deer blood, while cleaning deer carcasses. However, 
tick bites could not be ruled out, and there is also some 
question about the zoonotic potential of the organism 
carried in deer. Possible nosocomial and person-to-person 
transmission of A. phagocytophilum was reported in China, 
among relatives and healthcare workers who had contact 
with a patient with extensive hemorrhages. The organism 
was thought to have been transmitted by close, direct 
contact with blood and respiratory secretions. Additional 
studies are needed to confirm whether person-to-person 
transmission is possible in blood or other body secretions. 
Perinatal transmission of A. phagocytophilum has been 
documented in at least two people. The neonates were 
probably infected transplacentally or during delivery. 
Infection in breast milk could not be ruled out in one case. 
Transplacental transmission of A. phagocytophilum has 
been demonstrated in experimentally infected cattle. This 
organism was also reported in a retained, mummified 
canine fetus, but there was no evidence that any of the 
surviving puppies from the litter were infected. 
Disinfection 
There appears to be little or no research on the 
disinfectant susceptibility of these obligate intracellular 
pathogens. 
Infections in Humans 
Incubation Period 
Incubation periods from 5 to 21 days have been 
reported for ehrlichiosis and anaplasmosis. The U.S. 
Centers for Disease Control and Prevention (CDC) 
estimates that symptoms typically appear in 1-2 weeks.  
Clinical Signs 
In humans, the consequences of infection vary from 
asymptomatic infections or mild symptoms to a severe, 
potentially fatal illness. Clinical ehrlichiosis and 
anaplasmosis have similar symptoms, especially in the early 
stages; these diseases are all characterized by the acute 
onset of a nonspecific febrile illness, often (though not 
always) accompanied by thrombocytopenia, leukopenia and 
elevated levels of hepatic enzymes in the blood. However, 
there are some differences in the symptoms and severity of 
the illnesses.  
 
 
Human monocytic ehrlichiosis (E. chaffeensis) 
Significant numbers of healthy people have antibodies 
to E. chaffeensis in endemic areas, suggesting that 
unreported asymptomatic or mild infections might be 
relatively common. The syndromes caused by this organism 
vary from a mild febrile illness to fulminant disease with 
multi-organ failure. Fever occurs in almost all patients with 
documented human monocytic ehrlichiosis (HME), 
headaches in most, and myalgia and arthralgia in many 
patients. Less common symptoms include anorexia, 
coughing, nausea, vomiting, diarrhea and abdominal pain. 
Gastrointestinal signs are seen more often in children than 
adults. A skin rash has been reported in up to 66% of 
pediatric patients, but in less than 30% of adults. The rash is 
usually nonpruritic, and can be maculopapular, petechial or 
characterized by diffuse erythroderma. Commonly reported 
laboratory abnormalities include thrombocytopenia, mild to 
moderate leukopenia (especially lymphopenia) and elevated 
serum hepatic enzyme levels. Some patients also have 
anemia. 
Central nervous system (CNS) involvement, including 
meningitis or meningoencephalitis, is a potential 
complication in patients with HME. Other reported 
complications include opportunistic infections, 
cardiovascular failure, myocarditis, liver dysfunction, acute 
renal failure, interstitial pneumonia, respiratory distress 
syndrome, hemorrhages and disseminated intravascular 
coagulopathy, as well as a multisystemic disease that 
resembles toxic shock syndrome or septic shock. 
Complications, severe cases and deaths are more likely to 
be seen in elderly or immunocompromised patients, or in 
people with other concurrent illnesses, but fatal cases have 
been reported even in previously healthy, young patients. 
The case fatality rate in reported cases of HME is 
approximately 2-3%.  
Human granulocytic anaplasmosis (A. 
phagocytophilum) 
Similarly to HME, there is serological evidence of A. 
phagocytophilum infections in healthy people, and the 
clinical course in symptomatic cases ranges from mild to 
severe. Overall, human granulocytic anaplasmosis (HGA) 
tends to be less severe than HME. Fever, headache and 
myalgia are the most common signs. Less frequently 
reported symptoms include nausea, abdominal pain, 
diarrhea and cough. Rashes occur in less than 10% of 
patients. CNS involvement is uncommon, although rare 
cases of meningoencephalitis have been reported. In 
contrast, peripheral nervous system signs might be more 
common than in HME. Syndromes that have been described 
include cranial nerve palsies, brachial plexopathy, 
demyelinating polyneuropathy and bilateral facial nerve 
palsy. Neurological signs might result from coinfections 
with other tick-borne organisms (e.g., Borrelia burgdorferi) 
or opportunistic infections that result from impaired 
neutrophil function or leukopenia caused by A. 
Ehrlichiosis and Anaplasmosis 
Last Updated: January 2013 © 2013 page 4 of 14 
phagocytophilum. Other reported complications include 
acute renal failure, acute respiratory distress syndrome, 
cardiovascular collapse, pancarditis, hemorrhages and a 
septic or toxic shock-like syndrome. However, 
complications seem to be less frequent in HGA than HME. 
Leukopenia, thrombocytopenia and elevated serum levels 
of hepatic enzymes are the most common laboratory 
abnormalities. Patients with HGA may recover in 1-2 
weeks even without antibiotics; however, treatment is 
recommended in all symptomatic cases, as some untreated 
patients can become seriously ill. The case fatality rate is 
less than 1%, and most deaths are caused by complications 
from opportunistic infections or other concurrent illnesses.  
There have been concerns about the impact of A. 
phagocytophilum on pregnant women, both because the 
immune system is compromised during pregnancy, and 
because abortions and stillbirths occur in ruminants infected 
with this organism. Although little information is available, 
there is currently no evidence that A. phagocytophilum 
causes reproductive losses or severe sequelae in pregnant 
women. In one recent case series, no fulminant cases were 
seen in 6 pregnant women with HGA. Five of the 6 women 
responded very well to rifampin or doxycycline therapy, 
and one woman improved clinically without antibiotics and 
declined treatment. One newborn was infected perinatally, 
but responded well to treatment. No sequelae were reported 
in any of the infants, including the infected child, during the 
first 21 months of life. The report also described 3 similar 
cases previously reported in the literature. In addition, there 
is an earlier report of perinatal transmission. That infant 
(which developed fever and thrombocytopenia) was also 
treated successfully. 
Human ewingii ehrlichiosis (E. ewingii) 
Illnesses caused by E. ewingii have been reported in 
only a few patients, and little is known about the clinical 
signs. Although most documented cases occurred in 
immunocompromised patients, the symptoms were usually 
mild. Rash does not seem to be common. Leukopenia, 
thrombocytopenia and abnormal liver function tests were 
found in some cases, but not others. Few complications and 
no deaths have been reported. 
Infections with other organisms 
Only a few infections with Ehrlichia canis have been 
described in humans. One person with a chronic, 
asymptomatic infection and six infected people with 
ehrlichiosis symptoms were reported from Venezuela. In 
the clinical cases, all patients had a fever, and most had a 
headache and/or myalgia. Malaise, arthralgia, nausea, 
vomiting, rash, bone pain, diarrhea or abdominal pain 
occurred in some patients. Leukopenia was seen in one 
patient and anemia in another. All of the six patients were 
young and otherwise healthy, and the E. canis strains were 
identical to those seen in dogs. E. canis nucleic acids have 
also been detected in a small number of stored human serum 
samples in the U.S.  
Infections with an E. muris-like organism (“ehrlichia 
species Wisconsin”) in the U.S. were characterized by 
fever, fatigue and headache in 3 patients, as well as nausea 
and vomiting in a fourth patient. Laboratory abnormalities 
included lymphopenia, thrombocytopenia, and in some 
cases, elevated serum levels of hepatic enzymes. Two of the 
patients were on immunosuppressive medications for solid 
organ transplants. The other two were immunocompetent 
and had relatively mild illnesses. All four patients 
recovered with doxycycline treatment. 
Communicability 
A. phagocytophilum has been transmitted directly 
between people in blood transfusions, and Ehrlichia species 
might also be transmitted by this route. Leukocyte depletion 
of blood reduces but does not eliminate the risk. 
Transmission also seems to be possible in solid organ 
transplants. Perinatal transmission has been reported in two 
infants. 
Nosocomial transmission and possible person-to-
person transmission of A. phagocytophilum were reported 
in China. The cases occurred in healthcare workers and 
relatives in close, direct contact with a severely 
hemorrhaging patient who also underwent endotracheal 
intubation. Transmission was thought to have occurred in 
blood and/or respiratory secretions. The possibility of 
person-to-person transmission in blood or other body fluids 
remains to be confirmed. 
Diagnostic Tests 
The initial, presumptive diagnosis is usually based on 
the history and clinical signs, together with characteristic 
changes in platelet and leukocyte numbers and serum 
chemistry.  
Infections with E. chaffeensis (HME) or A. 
phagocytophilum (HGA) are confirmed most often by 
serology. Although antibodies are usually undetectable 
during the first 7–10 days of illness, these diseases can be 
diagnosed retrospectively by seroconversion or a 4-fold rise 
in paired antibody titers. Single positive titers may result 
from previous exposure. The indirect immunofluorescence 
assay (IFA) is the most commonly used serological test. 
Enzyme-linked immunosorbent assays (ELISAs) are also 
available, but they are qualitative rather than quantitative. 
There are no serological tests specific for E. ewingii; 
however, there is significant cross-reactivity between this 
organism and E. chaffeensis. Cross-reactions between 
bacteria in the genera Anaplasma, Ehrlichia and 
Neorickettsia can complicate definitive identification of 
some organisms. Some authors also report that early 
treatment with a tetracycline antibiotic occasionally reduces 
or eliminates antibody responses to E. chaffeensis. 
The detection of intracytoplasmic inclusions (morulae) 
in leukocytes is a quick method that may support the 
presumptive diagnosis. Morulae appear as stippled dark 
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blue or purple inclusions, and are found mainly in 
monocytes (E. chaffeensis, E. muris and E. canis) or 
neutrophils (A. phagocytophilum and E. ewingii), although 
they may be detected occasionally in other cell types. Only 
a small percentage of the cells are infected. Wright, Giemsa 
or Diff-Quik stained peripheral blood or buffy coat smears 
may be used to search for morulae, which are most likely to 
be found during the first week of illness. These structures 
disappear from the blood within 24–72 hours after starting 
doxycycline. Morulae are more likely to be found in HGA 
than HME; they are detected in 25-75% of the clinical cases 
caused by A. phagocytophilum, but they are usually 
detected in less than 10% of patients infected with E. 
chaffeensis. Morulae may also be found in the cerebrospinal 
fluid of patients with HME, but this is rare.  
Polymerase chain reaction (PCR) assays on blood or 
other samples may be the preferred test for definitive 
diagnosis, early in the disease. Only limited numbers of 
laboratories may run these assays. PCR is the only test that 
can identify E. ewingii infections. Organisms may also be 
observed directly in formalin-fixed tissue samples, using 
immunohistochemistry. This technique can be used on bone 
marrow biopsies, as well as on various autopsy samples 
including spleen, lymph node, liver and lung. 
Culture is used mainly in research, and is considered 
impractical for diagnosing routine clinical cases. It is 
difficult and time-consuming, and the specialized 
techniques needed are unavailable at most clinical 
laboratories. In addition, results may not be available for up 
to 2–6 weeks. Most Ehrlichia and Anaplasma species can 
be isolated in cell cultures. Several cell lines may be 
employed, but the DH82 canine histiocytic cell line is 
usually used to isolate E. chaffeensis, and human 
promyelocytic HL-60 cells for A. phagocytophilum. Species 
can be identified by PCR, and by sequencing and analysis 
of 16S rRNA. Successful in vitro cultivation of E. ewingii 
has not yet been reported. 
Treatment 
Ehrlichiosis and anaplasmosis are usually treated with 
tetracyclines; doxycycline is currently the drug of choice in 
people. Other antibiotics are occasionally employed, 
usually in circumstances where there are significant 
contraindications to the use of tetracyclines. Rifampin has 
been used successfully in some pregnant women. Early 
treatment is critical; uncomplicated cases usually respond 
promptly, but prolonged treatment may be necessary for 
severe or complicated cases. In suspected cases, antibiotics 
should be started before diagnostic confirmation is received 
from the laboratory.  
Prevention 
Avoidance of tick bites is the most cornerstone of 
prevention. Protective clothing (e.g., long-sleeved shirts and 
trousers tucked into socks) and footwear should be used in 
tick habitats. Ticks may be more visible on light-colored 
apparel. Clothing can be impregnated with acaricides such 
as permethrin. Tick repellents such as DEET are also 
helpful, although it should be kept in mind that they are 
only effective for a short period against ticks. For example, 
most tick repellents last less than 2 hours against 
Amblyomma spp. ticks. Clothing should be removed and 
decontaminated immediately after leaving a tick-infested 
environment. 
People who enter tick habitats should check frequently 
for ticks and remove them as soon as possible, using fine-
tipped tweezers, forceps, commercial tick removal devices 
or gloved hands. While the minimum attachment time for 
ticks to transmit Ehrlichia and Anaplasma is still uncertain, 
rapid tick removal is likely to reduce the infection risk. 
Bare hands should not be used to remove ticks, due to the 
risk of exposure to the tick’s fluids or feces; various tick-
transmitted disease organisms can enter the body through 
cuts in the skin or mucous membranes. If gloves are not 
available, the fingers should be shielded with a barrier, such 
as a tissue or paper towel. The tick should not be squeezed, 
crushed or punctured. The CDC warns that tick removal 
techniques such as the use of hot matches or petroleum jelly 
may stimulate it to release additional saliva and increase the 
risk of infection. The tick bite should be disinfected after 
removal, and the hands washed with soap and water. The 
tick can be frozen in a plastic bag, for identification in case 
of illness. Ticks should also be removed from pets, both to 
prevent them from becoming ill and to prevent ticks from 
entering the home. Acaricides, biological controls and 
modification of tick habitats can decrease tick populations.  
Prophylactic antibiotic therapy is not recommended 
after a tick bite, as the risk of infection is relatively low, and 
antibiotics can have adverse effects (including the 
development of antibiotic resistance). There is no vaccine 
for ehrlichiosis or anaplasmosis.  
Morbidity and Mortality 
Anaplasmosis and ehrlichiosis are more common at 
times of the year when tick activity is high and people are 
more likely to be outdoors. In the U.S., most cases of HME 
(E. chaffeensis) are seen from April to September, and the 
peak incidence of HGA (A. phagocytophilum) is in June 
and July. In Europe, the majority of HGA cases occur 
between June and August.  
Human anaplasmosis and ehrlichiosis are now 
reportable diseases in the U.S. The number of cases 
reported to the CDC has generally been increasing, due to 
increased awareness, new diagnostic tests and other factors. 
The reported incidence of HGA was 1.4 cases per million 
persons in 2000 and increased to 6.1 cases per million 
persons in 2010. During the same period, the incidence of 
HME from E. chaffeensis varied from less than 1 case per 
million persons (in 2000) to 3.4 cases per million persons 
(2008). Active surveillance suggests that the true incidence 
of both diseases may be higher in some areas: the number 
of HGA cases was as high as 24–58 cases per 100,000 
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population in Connecticut and the Upper Midwest, while up 
to 330–414 HME cases per 100,000 population were found 
in Tennessee and southeastern Missouri. HGA is also 
increasingly reported in Europe, where it is not a reportable 
disease. However, fewer cases have been documented than 
in the U.S., and these cases seem to be less severe. Some 
authors suggest that this might be caused by the presence of 
different A. phagocytophilum variants in each location. It is 
also possible that it results from lower physician awareness 
and decreased frequency of diagnostic testing.  
Although E. chaffeensis tends to cause more severe 
illness than A. phagocytophilum, asymptomatic or mild 
infections might be relatively common with both 
organisms. Serosurveillance suggests that up to 15-36% of 
the population in endemic areas worldwide has been 
exposed to A. phagocytophilum. Similarly, up to 13% of 
some populations may have antibodies to E. chaffeensis. In 
one endemic area, 20% of children with no history of HME 
were seropositive for this organism. The case fatality rate is 
estimated to be 2-3% for HME, and less than 1% for HGA. 
Although severe ehrlichiosis or anaplasmosis can be seen in 
healthy individuals, it is more common in 
immunocompromised or elderly patients, and in people 
with other illnesses,  
Human ewingii ehrlichiosis (E. ewingii) has been 
reported in only a few patients, most of whom were 
immunosuppressed. It is uncertain whether the small 
number of cases is due to the mildness of the condition, or 
the difficulty in definitive identification of E. ewingii. No 
deaths and few complications have been reported. 
Little is currently known about E. muris or E. canis 
infections in humans. E. muris was implicated in at least 2 
PCR-confirmed and 84 serologically diagnosed cases in 
Russia. In Japan, 1.1% of Tokyo residents had antibodies to 
this organism (although it is possible that this was due to 
cross-reactions with other organisms). An E. muris-like 
organism was linked to a few clinical cases in the U.S. 
Symptomatic cases caused by E. canis appear to be 
uncommon. 
Infections in Animals 
Species Affected 
Ehrlichia canis 
E. canis can cause illness in dogs and other canids, and 
these animals are thought to be the reservoir hosts. 
Evidence of infection with this or a similar organism has 
also been reported in cats and captive wild felids. An E. 
canis-like organism in South American felids might be a 
novel species. 
Ehrlichia chaffeensis 
White-tailed deer (Odocoileus virginianus) are 
probably the major reservoir hosts for E. chaffeensis in 
North America. This organism has also been detected by 
PCR in other cervids, including spotted deer (Cervus 
nippon) in Korea and Japan, and Brazilian marsh deer 
(Blastocerus dichotomus) in South America. Other wild and 
domesticated animals can also be infected. Antibodies to E. 
chaffeensis have been reported in raccoons (Procyon lotor), 
Virginia opossums (Didelphis virginiana), rabbits and 
foxes. Raccoons and red foxes (Vulpes vulpes) have been 
infected experimentally. Nucleic acids of E. chaffeensis 
were found in coyotes (Canis latrans) and wild lemurs in 
the U.S. Some surveys in North America suggest that 
antibodies are uncommon or absent in wild rodents; 
however, PCR evidence of an E. chaffeensis-like organism 
was reported from rodents in China and Korea. E. 
chaffeensis DNA was recently detected in a hawk during a 
survey of carnivorous birds in South America. Whether any 
of these animals can act as reservoir hosts is uncertain. 
Clinical cases have been documented in dogs and 
captive lemurs. Experimentally infected calves can also 
develop clinical signs, although there are currently no 
reports of illness in naturally infected cattle. Infections with 
E. chaffeensis have been reported in asymptomatic goats. 
Ehrlichia ewingii 
Little is known about E. ewingii, except that it can cause 
illness in dogs. Deer and dogs are proposed reservoir hosts. 
Ehrlichia muris 
E. muris DNA has been found in the blood of small 
rodents and deer. Rodents are probably the reservoir hosts 
Anaplasma phagocytophilum 
A. phagocytophilum can infect many species of wild 
and domesticated animals, and this organism is probably 
maintained in more than one cycle in nature. Among 
wildlife, there is molecular and/or serological evidence of 
infection in deer, moose (Alces alces) and other cervids, 
chamois (Rupicapra rupicapra), European bison (Bison 
bonasus), mountain lions (Puma concolor), Eurasian lynx 
(Lynx lynx), bears, red foxes, wild boar (Sus scrofa), 
raccoons, opossums, striped skunks (Mephitis mephitis), 
hares (Lepus capensis), rodents and birds. A. 
phagocytophilum has also been detected in lizards; 
however, these isolates seem to differ significantly from 
those found in mammals.  
Various wild rodents and cervids (while-tailed deer) 
are thought to act as reservoir hosts for A. phagocytophilum 
in North America. Some animals might maintain variants 
that are not pathogenic for humans or domesticated 
animals. In particular, some authors question the virulence 
of white-tailed deer isolates for people. Both livestock and 
wild ungulates, as well as wild rodents, might be reservoir 
hosts in Europe.  
There are reports of illnesses caused by A. 
phagocytophilum in many species including dogs, a captive 
timber wolf (Canis lupus occidentalis), cats, horses, cattle, 
sheep, goats, llamas, roe deer, reindeer and non-human 
primates. Different species can be affected in different 
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geographic regions. North American strains of A. 
phagocytophilum affect dogs, cats, horses and llamas, but 
do not seem to cause illness in domesticated ruminants. In 
contrast, the strains found in continental Europe can affect 
all of these species. 
Incubation Period 
Dogs infected with E. canis usually develop the acute 
form of canine monocytic ehrlichiosis within 2 to 4 weeks 
of the tick bite. The chronic form of this illness can occur 
months or years after the dog was infected.  
In ruminants A. phagocytophilum causes tick-borne 
fever 5 to 14 days after a tick bite, and 2 to 6 days after 
experimental transmission in blood. The incubation period is 
reported to be 1 to 3 weeks in horses (equine granulocytic 
anaplasmosis) and 1 to 2 weeks in dogs (canine granulocytic 
anaplasmosis).  
Clinical Signs 
Canine monocytic ehrlichiosis (E. canis) 
The outcome of infection with E. canis can vary from 
asymptomatic infection to severe, chronic illness. Three 
stages of canine monocytic ehrlichiosis (CME) – acute, 
subclinical and chronic – have been described in 
experimentally infected dogs. These stages may not be 
easy to distinguish in naturally infected animals. 
Concurrent infections with other organisms may increase 
the severity of disease. 
Some dogs, but not all, become acutely ill after 
infection with E. canis. They can develop a wide variety of 
clinical signs. Some dogs present with nonspecific signs 
such as fever, lethargy, anorexia, lymphadenopathy, 
splenomegaly and weight loss. Gastrointestinal signs 
(vomiting, diarrhea), lameness or stiffness, reluctance to 
walk, edema in the legs or scrotum, coughing, dyspnea and 
a serous to purulent oculonasal discharge may also be seen. 
Bleeding disorders, with petechiae, ecchymoses or mild 
epistaxis, have been reported. Ocular signs can occur in 
some dogs; reported syndromes include anterior uveitis, 
chorioretinitis, papilledema, retinal hemorrhages and 
perivascular infiltrates. Subretinal hemorrhages may lead to 
retinal detachment and blindness. Neurological signs, 
caused by meningitis and/or meningeal bleeding, are 
possible. Severe hepatitis with fever was the primary 
syndrome in one unusual case. Common laboratory 
abnormalities include thrombocytopenia and mildly 
elevated hepatic enzyme levels in serum, sometimes 
accompanied by leukopenia, leukocytosis or mild anemia. 
Although fatal cases are possible, the clinical signs can also 
resolve spontaneously. 
Some dogs that recover from acute illness, as well as 
some dogs that do not develop early clinical signs, remain 
subclinically infected for months or years. Mild 
thrombocytopenia is the most common laboratory 
abnormality in these animals. Subclinically infected dogs 
may eventually clear the organism, continue to remain 
infected but asymptomatic, or develop chronic disease. The 
conditions leading to the development of chronic illness are 
unknown.  
The clinical signs in chronic CME are similar to those 
in acute cases, but more severe, and vary with the organs 
affected. They often include fever, chronic weight loss, 
anorexia, weakness, lethargy, myalgia and edema. Bleeding 
disorders occur frequently, and may result in pale mucous 
membranes, petechiae, ecchymoses, epistaxis, hematuria, 
melena and ocular lesions. Anterior uveitis, retinal 
abnormalities and blindness have been reported. 
Pancytopenia, with variably severe combinations of 
leukopenia, thrombocytopenia and anemia, is common, and 
may lead to secondary infections. A minority of dogs 
develop neurological signs (e.g., ataxia, head tilt, 
nystagmus, meningitis, seizures, cranial nerve deficits, 
paraparesis or tetraparesis). Other reported complications 
include renal failure, interstitial pneumonia, liver disease 
(especially as a complication of bone marrow aplasia) and 
polymyositis. Reproductive disorders can include prolonged 
bleeding during estrus, inability to conceive, abortion and 
neonatal death. Chronic CME can be fatal. 
E. chaffeensis infections in dogs 
E. chaffeensis infections appear to be clinically 
indistinguishable from E. canis in dogs, but there is little 
specific information on this disease. In two reports, 
experimentally infected dogs developed only mild clinical 
signs. Fever was the only sign in one study, and 
thrombocytopenia was not detected. In the second report, 
dogs developed thrombocytopenia and became persistently 
infected for 2 to 4 months, but remained asymptomatic. 
More severe illness was reported in the few published cases 
reports. The clinical signs included hemorrhagic tendencies 
(e.g., petechiae, ecchymoses, hematuria, epistaxis), 
vomiting and lymphadenopathy. In one report, one of two 
dogs with hemorrhagic signs was coinfected with Babesia 
gibsoni. A dog coinfected with Leptospira grippotyphosa 
and E. chaffeensis had anterior uveitis and renal failure; the 
contribution of E. chaffeensis to the clinical signs is 
uncertain. Healthy dogs in endemic areas can also have 
antibodies to E. chaffeensis.  
Canine granulocytic ehrlichiosis (E. ewingii)  
Fever is the most common clinical sign in dogs 
infected with E ewingii. Other reported signs and 
laboratory abnormalities include lameness, neutrophilic 
polyarthritis, peripheral edema, lymphadenopathy, 
thrombocytopenia, anemia and elevated hepatic enzyme 
levels in serum. Some dogs may develop neurological 
signs. Fever (sometimes intermittent), thrombocytopenia 
and leukopenia were reported in experimentally infected 
dogs. Antibodies to E. ewingii can be found in healthy 
dogs in endemic areas. 
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Canine granulocytic anaplasmosis 
(A. phagocytophilum) 
Many healthy dogs have antibodies to A. 
phagocytophilum, suggesting that mild or subclinical 
infections might be common. In case series and clinical 
cases from Europe and U.S., lethargy and fever were the 
most frequently reported clinical signs in canine 
granulocytic anaplasmosis (CGA). Inappetence and 
musculoskeletal signs (lameness, joint pain, reluctance to 
move) were also common. Lameness is sometimes the 
result of neutrophilic polyarthritis. Other clinical signs may 
include infrequent coughing (usually soft and 
nonproductive), scleral injection, polydipsia, 
gastrointestinal signs (vomiting, diarrhea), splenomegaly, 
lymphadenopathy and hemorrhagic signs. Neurological 
signs seem to be uncommon. Laboratory abnormalities 
include thrombocytopenia in most dogs, and anemia, 
lymphopenia, leukopenia or mildly elevated levels of 
hepatic enzymes in the serum of some dogs. Fatal cases 
seem to be rare. 
A captive timber wolf with CGA developed fever, 
anorexia, lethargy, thrombocytopenia, lymphopenia and 
mild anemia, and responded to treatment with doxycycline. 
Ehrlichiosis and anaplasmosis in cats 
Ehrlichia spp. and A. phagocytophilum have been 
implicated only rarely in feline disease.  
Nonspecific signs of fever, lethargy and inappetence 
are the most commonly reported signs in cats with 
ehrlichiosis. Some cats also had myalgia, loss of condition, 
dyspnea, enlarged lymph nodes, polyarthritis, anemia, 
thrombocytopenia or pancytopenia.  
Fever, lethargy and inappetence are also the most 
common signs in cats infected with A. phagocytophilum. 
Joint pain, lameness, hemorrhagic signs (epistaxis, 
hematuria, pale mucous membranes), thrombocytopenia 
and anemia were reported in several cats. Enlarged lymph 
nodes were seen in some cats, but not others. Some cats 
also had weight loss, a tender abdomen, conjunctivitis, 
myalgia, neck rigidity, neurological signs (hyperesthesia, 
tremors, incoordination), vomiting, pharyngitis, polydipsia, 
gingivitis or periodontitis. Some clinical signs might have 
been caused by opportunistic infections associated with A. 
phagocytophilum-mediated immunosuppression.  
Equine granulocytic anaplasmosis (A. 
phagocytophilum) 
Equine granulocytic anaplasmosis has an acute onset 
and varies widely in severity. Young animals typically have 
mild cases, while adult horses (> 3 years old) tend to 
develop more severe syndromes. Horses under a year of age 
may only have a fever. In older animals, common clinical 
signs include fever, decreased appetite, lethargy, petechiae, 
icterus, reluctance to move, ataxia and distal limb edema, 
together with thrombocytopenia and leukopenia. Severe 
myopathy is possible. Transient ventricular arrhythmias 
occur on rare occasions, and concurrent infections may be 
exacerbated. Disseminated intravascular coagulation was 
reported in one experimentally infected horse. Deaths are 
uncommon in horses of all ages.  
Tick-borne fever (A. phagocytophilum) 
Tick-borne fever occurs in domesticated ruminants, 
particularly sheep and cattle. It has also been documented in 
goats, deer and reindeer.  
In sheep, this disease is mainly seen in young lambs 
born in tick-infested areas, and in newly introduced older 
sheep. The primary syndrome is a sudden fever that lasts 
for 4 to 10 days. Other signs are generally mild and may 
include inappetence, weight loss or decreased weight gain, 
listlessness, coughing and increased respiratory and pulse 
rates. Abortions and stillbirths can occur in pregnant ewes 
introduced onto infected pastures during the last stages of 
gestation; abortions are usually seen 2 to 8 days after the 
onset of the fever. Semen quality can be significantly 
reduced in rams. 
In cattle, tick-borne fever usually occurs in dairy 
animals recently turned out to pasture. The clinical signs are 
variable in severity, but may include lethargy, marked 
anorexia, decreased milk production, coughing, respiratory 
distress, abortions, stillbirths and reduced semen quality. 
The two most prominent syndromes are abortions with a 
drop in milk yield, and respiratory disease. 
In uncomplicated cases, animals usually recover within 
two weeks and deaths are uncommon except in aborting 
ewes. However, A. phagocytophilum increases the animal’s 
susceptibility to other illnesses, which may be serious or 
fatal. Tick pyemia, caused by Staphylococcus spp., is the 
most frequent and severe complication in young lambs. 
This illness is characterized by severe lameness, debility 
and paralysis, and many lambs die. Pasteurellosis and 
septicemic listeriosis are also common complications. 
Ehrlichia chaffeensis in ruminants 
Ehrlichiosis due to E. chaffeensis has not been reported 
in naturally infected ruminants. However, some dairy 
calves that were experimentally infected with this organism 
developed mild to severe illnesses. In mildly affected 
animals, the clinical signs included fever, decreased 
leukocyte numbers and reduced platelet counts. Calves with 
severe cases had fever and lethargy, followed by 
progressive muscular weakness in the hind limbs, 
recumbency and death. Neck twisting was also reported, 
possibly in response to cervical pain. One calf became 
recumbent but survived. The authors speculated that 
ehrlichiosis might not be seen in cattle because 
subtherapeutic doses of chlortetracycline are used to control 
other illnesses, such as bovine anaplasmosis, in endemic 
areas.  
No clinical signs, lesions or hematologic abnormalities 
were reported in deer experimentally infected with E. 
chaffeensis.  
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Ehrlichiosis in non-human primates 
E. chaffeensis caused an outbreak of ehrlichiosis in 
captive ring-tailed (Lemur catta) and red ruffed lemurs 
(Varecia variegata rubra). The clinical signs included 
fever, anorexia, lethargy, lymphadenopathy, 
thrombocytopenia and hyperbilirubinemia. Asymptomatic 
infections were detected in wild lemurs. Rhesus macaques 
and baboons experimentally infected with A. 
phagocytophilum had fever and anemia in one study, and 
fever, lethargy, anemia, thrombocytopenia and neutropenia 
in another. Severe disease was seen after experimental 
inoculation of rhesus macaques with E. canis. 
Communicability 
There is a risk of transmitting A. phagocytophilum, and 
possibly Ehrlichia spp., between animals in blood 
transfusions.  
Currently, the only published evidence suggesting 
direct transmission between people or animals consists of 
two case reports. In China, possible person-to-person 
transmission of A. phagocytophilum was reported in 
healthcare providers and relatives who were in close, direct 
contact with blood and respiratory secretions from a 
hemorrhaging patient. There is also a report of three people 
in the U.S. who might have become infected with A. 
phagocytophilum while cleaning deer carcasses. Although 
other sources of exposure (e.g., tick bites) could not be 
ruled out, the latter case suggests that care should be taken 
when handling blood and tissues from animals.  
Animals can increase human exposure by introducing 
infected ticks into the home. 
Diagnostic Tests 
Ehrlichiosis and anaplasmosis can be diagnosed by 
serology or detection of the organism. Hematologic 
abnormalities, changes in serum chemistry (e.g., elevated 
hepatic enzyme levels in serum) and a response to treatment 
also help support the diagnosis.  
Serological tests are often used to diagnose 
anaplasmosis and ehrlichiosis. Seroconversion or a rising 
titer is diagnostic. Single titers should be interpreted with 
caution, as antibodies can often be found in healthy 
animals. Conversely, antibodies may not be detectable in 
sick animals, early in the disease. Indirect 
immunofluorescent antibody tests for E canis and A. 
phagocytophilum are widely available at diagnostic 
laboratories. Because E. ewingii has yet not been cultivated 
in vitro, no assays have been developed for this organism; 
however, sera from dogs infected with E. ewingii may react 
in the E. canis IFA. Antibodies to E canis and A. 
phagocytophilum can also be detected with ELISA tests. 
These ELISAs were developed for dogs, but they are not 
species specific (although they have not necessarily been 
validated in other animals). Cross-reactions may be seen 
among bacteria in the genera Anaplasma, Ehrlichia and 
Neorickettsia. Immunoblotting (Western blotting) can be 
used to distinguish serological reactions to different species, 
including E. ewingii. This test is mainly used in research.  
The detection of intracytoplasmic inclusions (morulae) 
in leukocytes can support the diagnosis in acutely infected 
animals. However, this test does not specifically identify 
Ehrlichia and Anaplasma. Morulae appear as stippled dark 
blue or purple inclusions mainly in monocytes (E. canis, E. 
chaffeensis and E. muris) or neutrophils (A. 
phagocytophilum or E. ewingii), although they may be 
found occasionally in other cell types. Wright, Giemsa or 
Diff-Quik stained peripheral blood, bone marrow smears, 
lymph node smears or other impression smears from fresh 
tissues may be used to search for morulae. They are most 
likely to be found early in the acute illness, and disappear 
from the blood soon after starting tetracycline treatment. 
Morulae are rarely detected in chronic CME. The 
probability of detecting morulae in blood smears also varies 
with the pathogen and host species. Up to 90% of the 
granulocytes in ruminants might contain A. 
phagocytophilum morulae during peak bacteremia; 
however, only 7-32% of the neutrophils in dogs, and up to 
30-40% of the granulocytes in horses contain these 
inclusions. In four case series, A. phagocytophilum morulae 
were detected in blood smears from 36-100% of infected 
dogs. Inclusions can also be found in significant number of 
dogs infected with E. ewingii. In contrast, E. canis and E. 
chaffeensis morulae are uncommon in blood (although the 
use of buffy coat may be more successful). One estimate 
suggests that they are found in only 4% of dogs infected 
with E. canis.  
PCR assays that detect nucleic acids of E. canis, E. 
chaffeensis, E. ewingii or A. phagocytophilum may be 
available, usually from veterinary schools or research 
laboratories. Several different assays are used, and they can 
vary in sensitivity and specificity. Peripheral blood is often 
tested, but other samples, such as bone marrow or spleen 
tissue, can also be used. Sequencing of the PCR product 
may be necessary, as some tests can amplify other 
organisms. PCR does not always detect very small numbers 
of organisms, such as E. canis in the peripheral blood of 
subclinically or chronically infected dogs. Blood samples 
for PCR should be taken before antibiotics are begun, to 
maximize the chance of finding organisms.  
Culture is used mainly in research, and is considered 
impractical for diagnosing routine clinical cases. It is 
difficult and time-consuming, and the specialized 
techniques needed are unavailable at most clinical 
laboratories. In addition, results may not be available for up 
to 2–6 weeks. Most Ehrlichia and Anaplasma species can 
be isolated in cell cultures. Several cell lines may be 
employed, but the DH82 canine histiocytic cell line is 
usually used to isolate E. chaffeensis, and human 
promyelocytic HL-60 cells for A. phagocytophilum. Species 
can be identified by PCR, and by sequencing and analysis 
of 16S rRNA. Successful in vitro cultivation of E. ewingii 
has not yet been reported. 
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Treatment 
Only a limited number of antibiotics are effective for 
treating ehrlichiosis and granulocytic anaplasmosis. 
Tetracycline antibiotics, such as oxytetracycline in 
ruminants and horses, and doxycycline in dogs and cats, are 
usually the treatment of choice. Rifampin has been used 
occasionally in dogs, as well as in people. Early treatment is 
critical for canine ehrlichiosis caused by E. canis; 
uncomplicated acute cases usually respond promptly, but 
antibiotics may be less effective in dogs with neurological 
signs, and treatment of the chronic severe form is difficult. 
Animals infected with A. phagocytophilum usually respond 
well. Some cases of ehrlichiosis or anaplasmosis require 
supportive therapy, such as blood or platelet transfusions, or 
antibiotics for secondary infections.  
Some studies document complete clearance of the 
organisms with doxycycline, while others suggest that they 
sometimes persist inapparently in animals, including dogs.  
Prevention 
Tick control is the cornerstone of prevention for 
ehrlichiosis and anaplasmosis.  
Acaricides, including some monthly topical acaricides 
used for flea and tick control, can decrease the risk of 
infections in pets. However, no acaricide can entirely 
eliminate ticks or the risk of illness. Pets that enter tick-
infested environments should be inspected frequently, and 
ticks should be removed promptly with fine-tipped 
tweezers, forceps, commercial tick removal devices or 
gloved hands, as for humans. Biological controls and 
habitat modification (e.g., eliminating brush) can also 
decrease tick populations. Prophylactic tetracycline 
antibiotics have been used in dogs in some situations, but 
some authors consider this to be an impractical method of 
prevention. In addition, antibiotics can increase the risk of 
resistance in any bacteria (including non-target organisms) 
that are exposed. Some authors suggest PCR testing for A. 
phagocytophilum in dogs used as blood donors.  
Tick-borne fever is usually controlled by periodic 
treatment of ruminants with acaricides. One disadvantage of 
frequent exposure is that ticks may become resistant to 
these agents. The risk of illness can also be reduced by 
grazing animals on relatively tick-free pastures. One 
method to control this disease in lambs is to keep them in 
tick-free pastures, with their dams, until they are 
approximately 6-7 weeks old. Occasionally, ruminants that 
are moved from tick-free environments to infested pastures 
are treated prophylactically with long-acting tetracyclines. 
However, this is not a common method of control. 
No vaccines are available.  
Morbidity and Mortality 
Dog and cats 
Asymptomatic infections appear to be relatively 
common in dogs. Antibodies to A. phagocytophilum or 
some species of Ehrlichia can be found in up to 50-60% of 
the dogs in some areas, usually without any evidence of a 
previous illness. Although cross-reactions can complicate 
definitive identification in serological surveys, E ewingii 
and E chaffeensis are thought to be more common in dogs 
than E canis in some parts of North America. In dogs, 
anaplasmosis and ehrlichiosis are somewhat seasonal. 
Acute cases are more common during warm weather, when 
tick activity is high and outdoor recreation is more 
common. However, populations of the tick vector for E. 
canis can become established indoors in houses and 
kennels, and cases of canine monocytic ehrlichiosis are 
diagnosed year round. In addition, chronic CME can 
develop at any time, due to the long and variable incubation 
period.  
Among the organisms known to cause illness in dogs, 
E canis is considered to be the most important agent 
worldwide, due to the potential severity of the illness and 
the difficulty in curing chronic cases. German shepherds 
seem to be particularly susceptible to developing severe 
CME; however, virulent strains of E. canis can cause 
serious illness in all breeds of dogs. Other organisms can 
also cause severe anaplasmosis or ehrlichiosis, but overall, 
infections with E. chaffeensis or A. phagocytophilum are 
thought to be milder. However, some organisms that infect 
dogs are still incompletely understood. 
Antibodies to Ehrlichia spp. and A. phagocytophilum 
have also been reported among cats in Europe and North 
and South America, with seroprevalence rates as high as 
17% in some locations. Clinical cases seem to be 
uncommon in this species. It is not known whether these 
diseases are under-reported, cats are less susceptible to 
illness, or if they simply remove ticks during self-grooming 
and thus are infected less often.  
Livestock 
Equine granulocytic anaplasmosis occurs in both 
Europe and the Americas. This illness is typically milder in 
young horses (especially animals under a year of age), but 
deaths are uncommon at all ages. In some areas, relatively 
large numbers of horses have antibodies to A. 
phagocytophilum.  
Tick-borne fever of ruminants has been reported only 
from the Eastern Hemisphere. In Europe, this disease 
usually occurs as a spring and early summer epidemic when 
dairy cattle are turned out to pasture. In sheep, the illness is 
seen most often in young lambs born in tick-infested areas, 
and in older sheep introduced to such areas. Breed-specific 
differences in susceptibility have been reported in sheep. 
Tick-borne fever can be a major economic burden in some 
areas. Although the illness is rarely fatal by itself, 
secondary infections, especially tick pyemia in lambs, can 
be serious or fatal. Abortion storms may be seen if pregnant 
sheep or cattle in the late stages of gestation are introduced 
to tick-infested pastures. Up to 90% of naive pregnant ewes 
can be affected. Decreased weight gain in lambs, and 
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reduced milk yield in cattle also cause losses. Although 
ruminants in endemic areas can develop immunity to A. 
phagocytophilum, it seems to be variable, and may fall 
quickly if animals are removed from tick-infested areas.  
Post Mortem Lesions      Click to view images 
Canine ehrlichiosis and anaplasmosis 
The gross lesions are usually nonspecific in acute 
cases, but typically include enlargement of the spleen. 
Hemorrhagic lesions in severe canine ehrlichiosis can affect 
numerous organs including the gastrointestinal tract, heart, 
bladder, lungs, subcutaneous tissues and eyes. The lymph 
nodes, particularly the mesenteric nodes, may be enlarged, 
with red and brown discoloration on cut surface. There may 
be edema in the legs, as well as ascites and 
hydropericardium. In chronic CME, splenomegaly and 
nonspecific lesions may be accompanied by widespread 
hemorrhages, and microscopically by mononuclear cell 
infiltration into the perivascular area in multiple organs. 
Equine granulocytic anaplasmosis 
The characteristic lesions of equine granulocytic 
anaplasmosis are petechiae, ecchymoses and edema in the 
subcutaneous tissues and fascia, mainly in the legs. 
Interstitial pneumonitis has been reported in some animals. 
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